Abstract:Objective To investigate the clinical effect of laparoscopic D2 radical gastrectomy combined with radiofrequency ablation for liver metastasis of gastric cancer.Methods 62 patients with liver metastasis of resectable gastric cancer treated from January 2017 to January 2020 were selected and randomly divided into control group and observation group with 31 cases in each group. The control group was treated with open D2 radical gastrectomy combined with radiofrequency ablation, and the observation group was treated with laparoscopic D2 radical gastrectomy combined with radiofrequency ablation. The operation indexes, serum tumor markers, immune related indexes and complications were compared between the two groups.Results The intraoperative blood loss in the control group was more than that in the observation group, the intestinal function recovery time and hospitalization time of the control group were significantly longer than those of the observation group (P < 0.05), and the operation time was shorter than that of the observation group (P < 0.05); the levels of serum alpha fetoprotein (AFP) and carcinoembryonic antigen (CEA) decreased in the two groups after operation (P < 0.05), and the serum AFP and CEA level of the observation group were lower than those of the control group (P < 0.05); the postoperative CD4+, CD8+, CD4+/CD8+ levels of the two groups were lower than those before operation, the levels of CD4+, CD4+/CD8+ in the observation group were significantly higher than those in the control group (P < 0.05); the incidence of complications in the observation group was 12.90%, which was lower than 41.94% in the control group (P < 0.05).Conclusion Laparoscopic D2 radical gastrectomy combined with radiofrequency ablation in treatment of liver metastasis of gastric cancer is conducive to postoperative rehabilitation, significantly improve serum tumor markers and immune function, and reduce the incidence of perioperative complications.